Mylan, IRS Trade Opening Shots Ahead Of $100M Tax Trial
By Jimmy Hoover · May 9, 2017, 10:11 PM EDT
Mylan and the IRS have exchanged opening salvos in a $100 million tax fight relating to its transaction with Forest Laboratories Holdings Ltd. over the anti-hypertensive compound nebivolol, submitting dueling briefs...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login